A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Clinical trial NCT06565611 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06565611
- Sponsor
- Palatin Technologies, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-05
- Primary completion
- 2025-02-05
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.